...
首页> 外文期刊>Biostatistics >Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data
【24h】

Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data

机译:随机结果发生后对治疗结果的平均因果影响的半参数估计,缺少结果数据

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the past decade, several principal stratification-based statistical methods have been developed for testing and estimation of a treatment effect on an outcome measured after a postrandomization event. Two examples are the evaluation of the effect of a cancer treatment on quality of life in subjects who remain alive and the evaluation of the effect of an HIV vaccine on viral load in subjects who acquire HIV infection. However, in general the developed methods have not addressed the issue of missing outcome data, and hence their validity relies on a missing completely at random (MCAR) assumption. Because in many applications the MCAR assumption is untenable, while a missing at random (MAR) assumption is defensible, we extend the semiparametric likelihood sensitivity analysis approach of Gilbert and others (2003) and Jemiai and Rotnitzky (2005) to allow the outcome to be MAR. We combine these methods with the robust likelihood-based method of Little and An (2004) for handling MAR data to provide semiparametric estimation of the average causal effect of treatment on the outcome. The new method, which does not require a monotonicity assumption, is evaluated in a simulation study and is applied to data from the first HIV vaccine efficacy trial.
机译:在过去的十年中,已经开发了几种基于分层的主要统计方法,用于测试和评估对随机后事件后测量的结局的治疗效果。两个例子是评估癌症治疗对活着的受试者的生活质量的影响,以及评估HIV疫苗对感染HIV的受试者的病毒载量的影响。但是,一般而言,已开发的方法尚未解决缺少结果数据的问题,因此,其有效性依赖于完全随机缺失(MCAR)的假设。因为在许多应用中,MCAR假设是站不住脚的,而随机缺失(MAR)假设是可以辩护的,所以我们扩展了Gilbert等人(2003)以及Jemiai和Rotnitzky(2005)的半参数似然敏感性分析方法,以便得出结果3月我们将这些方法与基于稳健的基于似然性的Little and An(2004)处理MAR数据的方法结合起来,以提供对治疗结果的平均因果效应的半参数估计。这项新方法不需要单调性假设,已在模拟研究中进行了评估,并将其应用于首次HIV疫苗功效试验的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号